Protara Therapeutics Inc - Avancerat diagram FX Empire

Årets amerikanska 1000-procentare Placera

Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest Protara Therapeutics Inc. (TARA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Protara Therapeutics Inc (TARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

1. Avaktivera utvecklarläge
2. Hyr ut stuga
3. Röda prickar efter rakning bikinilinjen
4. Hyra båt i magelungen
5. International school of stockholm
6. Sharefile pricing
7. Hur många invånare i örebro
8. Ekonomi resultatdiagram

2021-04-10 · Renaissance Technologies LLC lowered its holdings in Protara Therapeutics, Inc. (NASDAQ:TARA) by 54.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,110 shares of the company’s stock after selling 20,676 shares during the period. Renaissance Technologies LLC owned approximately 0.15% of […] Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. 2021-03-05 · View today's stock price, news and analysis for Protara Therapeutics Inc. (TARA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation PROTARA THERAPEUTICS, INC. : News, information and stories for PROTARA THERAPEUTICS, INC. | Nasdaq: TARA | Nasdaq 2021-03-21 · Currently, the analyst consensus on Protara Therapeutics is a Moderate Buy with an average price target of $41.50, a 136.1% upside from current levels. In a report issued on March 12, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $40.00 price target.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company.

Protara Therapeutics Inc Teknisk analys av aktie TARA

2021-04-06 Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find real-time TARA - Protara Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Protara Therapeutics Inc Aktienyheter TARA - Investing.com

Share your opinion and gain insight from other stock traders and investors.

View detailed financial information, real-time news, videos, quotes and analysis on Protara Therapeutics, Inc. (NASDAQ:TARA). Explore commentary on Protara Therapeutics, Inc. and hear what the Protara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TARA updated stock price target summary. 2020-10-05 · The Average True Range (ATR) for Protara Therapeutics Inc. is set at 1.35 The Price to Book ratio for the last quarter was 1.80. Trading performance analysis for TARA stock.
Asa edman kallstromer

Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Thursday, March 14, 2019.
Konsumentkreditlag

svenska rap låtar text
trygg hansa fastighetsförsäkring
idrottsläkare malmö
kiruna icehotel
tavla göteborgs hamn
nordea abp share price
lediga jobb larmtekniker göteborg

• CDar
• xhqh
• nZE
• eg
• dqI

• Skatteverket stockholm kontor
• Theater brecht berlin
• Saranda restaurang uppsala
• Agresso system requirements
• Datum årsredovisning 2021
• Matte grund 4
• Lilla tyrolen adress
• Lilis burger and pizza uppsala
• Petrograd ww1

Förväntade resultat, Page 1 Scanaktier.se

View real-time stock prices and stock quotes for a full financial overview. 2021-03-31 · Stock analysis for Protara Therapeutics Inc (TARA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Stock analysis for Protara Therapeutics Inc (PRTO) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

MSØ Shareville

View real-time stock prices and stock quotes for a full financial overview.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases. Its development programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology/gastrointestinal and metabolic disorders. View detailed financial information, real-time news, videos, quotes and analysis on Protara Therapeutics, Inc. (NASDAQ:TARA).